Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab
Description

The purpose of this study was to evaluate the efficacy observed with canakinumab dose reduction in a subgroup of patients in the extension study CACZ885G2301E1.

Conditions

Systemic Juvenile Idiopathic Arthritis (SJIA)